{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:26Z","timestamp":1787020646114,"version":"build-2736575974"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG058772"],"award-info":[{"award-number":["R01 AG058772"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FAPESP - The State of S\u00e3o Paulo Research Foundation","award":["#2015\/10109-5"],"award-info":[{"award-number":["#2015\/10109-5"]}]},{"name":"National Institute of Health","award":["R00 AG047282; R01 MH126979; R21 EB034184"],"award-info":[{"award-number":["R00 AG047282; R01 MH126979; R21 EB034184"]}]},{"name":"National Institute of Health","award":["R01 AG054046, RF1 AG054991, R01 AG066203, RF1 AG079251"],"award-info":[{"award-number":["R01 AG054046, RF1 AG054991, R01 AG066203, RF1 AG079251"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARFD-24-1307665"],"award-info":[{"award-number":["AARFD-24-1307665"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03432-4","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T03:06:01Z","timestamp":1744686361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Analysis and interpretation of inflammatory fluid markers in Alzheimer\u2019s disease: a roadmap for standardization"],"prefix":"10.1186","volume":"22","author":[{"given":"Brianne M.","family":"Bettcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio Ferreira","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auriel A.","family":"Willette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata M.","family":"Michalowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Santos","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Rajbanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyllians V.","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mal\u00fa G\u00e1mez","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyani","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"3432_CR1","doi-asserted-by":"crossref","unstructured":"Jack CR Jr., Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease. Alzheimer\u2019s Association Workgroup. Alzheimers Dement; 2024.","DOI":"10.1002\/alz.13859"},{"key":"3432_CR2","doi-asserted-by":"crossref","unstructured":"Consortium AB, Jia Y-J, Wang J et al. A framework of biomarkers for brain aging: a consensus statement by the aging biomarker consortium. Life Med 2023;2.","DOI":"10.1093\/lifemedi\/lnad033"},{"key":"3432_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312\u201325.","journal-title":"Nat Neurosci"},{"key":"3432_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2017.01.020","volume":"62","author":"J Popp","year":"2017","unstructured":"Popp J, Oikonomidi A, Tautvydaite D, et al. Markers of neuroinflammation associated with Alzheimer\u2019s disease pathology in older adults. Brain Behav Immun. 2017;62:203\u201311.","journal-title":"Brain Behav Immun"},{"key":"3432_CR5","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/alz.12545","volume":"18","author":"C Delaby","year":"2022","unstructured":"Delaby C, Teunissen CE, Blennow K, et al. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease: an international overview. Alzheimers Dement. 2022;18:1868\u201379.","journal-title":"Alzheimers Dement"},{"key":"3432_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/alz.12510","volume":"18","author":"IMW Verberk","year":"2022","unstructured":"Verberk IMW, Misdorp EO, Koelewijn J, et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease-related blood-based biomarkers: results from the standardization of Alzheimer\u2019s blood biomarkers (SABB) working group. Alzheimers Dement. 2022;18:1484\u201397.","journal-title":"Alzheimers Dement"},{"key":"3432_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R, et al. Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol. 2018;136:821\u201353.","journal-title":"Acta Neuropathol"},{"key":"3432_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"3432_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med. 2007;13:1359\u201362.","journal-title":"Nat Med"},{"key":"3432_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00401-010-0723-9","volume":"120","author":"WT Hu","year":"2010","unstructured":"Hu WT, Chen-Plotkin A, Arnold SE, et al. Biomarker discovery for Alzheimer\u2019s disease, frontotemporal Lobar degeneration, and Parkinson\u2019s disease. Acta Neuropathol. 2010;120:385\u201399.","journal-title":"Acta Neuropathol"},{"key":"3432_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh SKL, Wolters FJ, Ikram MA, de Wolf F, Bos D, Hofman A. Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: A meta-analysis. Alzheimers Dement. 2018;14:1450\u20139.","journal-title":"Alzheimers Dement"},{"key":"3432_CR12","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1038\/s41467-021-24220-7","volume":"12","author":"WT Hu","year":"2021","unstructured":"Hu WT, Ozturk T, Kollhoff A, Wharton W, Christina Howell J. Alzheimer\u2019s disease neuroimaging I. Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer\u2019s disease. Nat Commun. 2021;12:4001.","journal-title":"Nat Commun"},{"key":"3432_CR13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/gerona\/gly217","volume":"74","author":"AMV Wennberg","year":"2019","unstructured":"Wennberg AMV, Hagen CE, Machulda MM, Knopman DS, Petersen RC, Mielke MM. The Cross-sectional and longitudinal associations between IL-6, IL-10, and TNFalpha and cognitive outcomes in the Mayo clinic study of aging. J Gerontol Biol Sci Med Sci. 2019;74:1289\u201395.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"3432_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-030-78787-5_6","volume":"1339","author":"M Katsoulaki","year":"2021","unstructured":"Katsoulaki M, Kastrinis A, Konstantoudaki X, Tsekoura M. The role of inflammatory biomarkers as a diagnostic tool for possible Late-Life cognitive decline and dementias. Adv Exp Med Biol. 2021;1339:39\u201346.","journal-title":"Adv Exp Med Biol"},{"key":"3432_CR15","doi-asserted-by":"publisher","first-page":"e0244612","DOI":"10.1371\/journal.pone.0244612","volume":"15","author":"M Arce Renteria","year":"2020","unstructured":"Arce Renteria M, Gillett SR, McClure LA, et al. C-reactive protein and risk of cognitive decline: the REGARDS study. PLoS ONE. 2020;15:e0244612.","journal-title":"PLoS ONE"},{"key":"3432_CR16","doi-asserted-by":"publisher","unstructured":"Yang HS, Zhang C, Carlyle BC, et al. Plasma IL-12\/IFN-gamma axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 2022;18:645\u201353. https:\/\/doi.org\/10.1002\/alz.12399.","DOI":"10.1002\/alz.12399"},{"key":"3432_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3233\/JAD-170887","volume":"63","author":"PF Meyer","year":"2018","unstructured":"Meyer PF, Savard M, Poirier J, et al. Bi-directional association of cerebrospinal fluid immune markers with stage of Alzheimer\u2019s disease pathogenesis. J Alzheimers Dis. 2018;63:577\u201390.","journal-title":"J Alzheimers Dis"},{"key":"3432_CR18","doi-asserted-by":"crossref","unstructured":"Ewers M, Franzmeier N, Suarez-Calvet M et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med 2019;11.","DOI":"10.1126\/scitranslmed.aav6221"},{"key":"3432_CR19","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/brain\/awg175","volume":"126","author":"M Sailer","year":"2003","unstructured":"Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain. 2003;126:1734\u201344.","journal-title":"Brain"},{"key":"3432_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","volume":"33","author":"J McAfoose","year":"2009","unstructured":"McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009;33:355\u201366.","journal-title":"Neurosci Biobehav Rev"},{"key":"3432_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12974-016-0744-y","volume":"13","author":"BM Flannery","year":"2016","unstructured":"Flannery BM, Bruun DA, Rowland DJ, et al. Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication. J Neuroinflammation. 2016;13:267.","journal-title":"J Neuroinflammation"},{"key":"3432_CR22","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822\u201332.","journal-title":"Nat Med"},{"key":"3432_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/gerona\/gly121","volume":"74","author":"D Parker","year":"2019","unstructured":"Parker D, Sloane R, Pieper CF, et al. Age-Related adverse inflammatory and metabolic changes begin early in adulthood. J Gerontol Biol Sci Med Sci. 2019;74:283\u20139.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"3432_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","volume":"90","author":"XN Shen","year":"2019","unstructured":"Shen XN, Niu LD, Wang YJ, et al. Inflammatory markers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies. J Neurol Neurosurg Psychiatry. 2019;90:590\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3432_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"HS Yang","year":"2022","unstructured":"Yang HS, Zhang C, Carlyle BC, et al. Plasma IL-12\/IFN-gamma axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 2022;18:645\u201353.","journal-title":"Alzheimers Dement"},{"key":"3432_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.trci.2016.05.001","volume":"2","author":"LJ Van Eldik","year":"2016","unstructured":"Van Eldik LJ, Carrillo MC, Cole PE, et al. The roles of inflammation and immune mechanisms in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2016;2:99\u2013109.","journal-title":"Alzheimers Dement (N Y)"},{"key":"3432_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u201367.","journal-title":"Lancet Neurol"},{"key":"3432_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/glia.22350","volume":"61","author":"C Cunningham","year":"2013","unstructured":"Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia. 2013;61:71\u201390.","journal-title":"Glia"},{"key":"3432_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic States. Br J Pharmacol. 2016;173:649\u201365.","journal-title":"Br J Pharmacol"},{"key":"3432_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1073\/pnas.1111924109","volume":"109","author":"V Ramaglia","year":"2012","unstructured":"Ramaglia V, Hughes TR, Donev RM, et al. C3-dependent mechanism of microglial priming relevant to multiple sclerosis. Proc Natl Acad Sci U S A. 2012;109:965\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3432_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early synapse loss in alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"3432_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2990.2012.01306.x","volume":"39","author":"DM Norden","year":"2013","unstructured":"Norden DM, Godbout JP. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol. 2013;39:19\u201334.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3432_CR33","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","volume":"33","author":"AH Stephan","year":"2013","unstructured":"Stephan AH, Madison DV, Mateos JM, et al. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci. 2013;33:13460\u201374.","journal-title":"J Neurosci"},{"key":"3432_CR34","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, et al. Microglia States and nomenclature: A field at its crossroads. Neuron. 2022;110:3458\u201383.","journal-title":"Neuron"},{"key":"3432_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41593-024-01600-y","volume":"27","author":"R Mancuso","year":"2024","unstructured":"Mancuso R, Fattorelli N, Martinez-Muriana A, et al. Xenografted human microglia display diverse transcriptomic States in response to Alzheimer\u2019s disease-related amyloid-beta pathology. Nat Neurosci. 2024;27:886\u2013900.","journal-title":"Nat Neurosci"},{"key":"3432_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-8993(93)90959-Q","volume":"628","author":"FP Bellinger","year":"1993","unstructured":"Bellinger FP, Madamba S, Siggins GR. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 1993;628:227\u201334.","journal-title":"Brain Res"},{"key":"3432_CR37","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1471-4159.2006.04165.x","volume":"99","author":"R Griffin","year":"2006","unstructured":"Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA. The age-related Attenuation in long-term potentiation is associated with microglial activation. J Neurochem. 2006;99:1263\u201372.","journal-title":"J Neurochem"},{"key":"3432_CR38","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.neuroscience.2009.08.073","volume":"164","author":"AH Moore","year":"2009","unstructured":"Moore AH, Wu M, Shaftel SS, Graham KA, O\u2019Banion MK. Sustained expression of interleukin-1beta in mouse hippocampus impairs Spatial memory. Neuroscience. 2009;164:1484\u201395.","journal-title":"Neuroscience"},{"key":"3432_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1172\/JCI31450","volume":"117","author":"SS Shaftel","year":"2007","unstructured":"Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE, O\u2019Banion MK. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates alzheimer plaque pathology. J Clin Invest. 2007;117:1595\u2013604.","journal-title":"J Clin Invest"},{"key":"3432_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","volume":"25","author":"R Yirmiya","year":"2011","unstructured":"Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25:181\u2013213.","journal-title":"Brain Behav Immun"},{"key":"3432_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25543","volume":"86","author":"W Wharton","year":"2019","unstructured":"Wharton W, Kollhoff AL, Gangishetti U, et al. Interleukin 9 alterations linked to alzheimer disease in African Americans. Ann Neurol. 2019;86:407\u201318.","journal-title":"Ann Neurol"},{"key":"3432_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13195-022-01039-y","volume":"14","author":"AHYS Hok","year":"2022","unstructured":"Hok AHYS, Hoozemans JJM, Hu WT, et al. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer\u2019s disease and frontotemporal Lobar degeneration. Alzheimers Res Ther. 2022;14:100.","journal-title":"Alzheimers Res Ther"},{"key":"3432_CR43","first-page":"314185","volume":"2012","author":"TM Weitz","year":"2012","unstructured":"Weitz TM, Town T. Microglia in Alzheimer\u2019s disease: it\u2019s all about context. Int J Alzheimers Dis. 2012;2012:314185.","journal-title":"Int J Alzheimers Dis"},{"key":"3432_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.nbd.2005.05.002","volume":"20","author":"G Ophir","year":"2005","unstructured":"Ophir G, Amariglio N, Jacob-Hirsch J, Elkon R, Rechavi G, Michaelson DM. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol Dis. 2005;20:709\u201318.","journal-title":"Neurobiol Dis"},{"key":"3432_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1742-2094-2-24","volume":"2","author":"T Town","year":"2005","unstructured":"Town T, Nikolic V, Tan J. The microglial activation continuum: from innate to adaptive responses. J Neuroinflammation. 2005;2:24.","journal-title":"J Neuroinflammation"},{"key":"3432_CR46","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s12035-023-03329-4","volume":"60","author":"I Korczowska-Lacka","year":"2023","unstructured":"Korczowska-Lacka I, Hurla M, Banaszek N, et al. Selected biomarkers of oxidative stress and energy metabolism disorders in neurological diseases. Mol Neurobiol. 2023;60:4132\u201349.","journal-title":"Mol Neurobiol"},{"key":"3432_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0920-1211(96)00030-7","volume":"25","author":"MG Naffah-Mazzacoratti","year":"1996","unstructured":"Naffah-Mazzacoratti MG, Amado D, Cukiert A, et al. Monoamines and their metabolites in cerebrospinal fluid and Temporal cortex of epileptic patients. Epilepsy Res. 1996;25:133\u20137.","journal-title":"Epilepsy Res"},{"key":"3432_CR48","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","volume":"69","author":"FG Joseph","year":"2007","unstructured":"Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology. 2007;69:644\u201354.","journal-title":"Neurology"},{"key":"3432_CR49","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10072-012-1161-3","volume":"34","author":"FF de Oliveira","year":"2013","unstructured":"de Oliveira FF, Cardoso TA, Sampaio-Barros PD, Damasceno BP. Normal pressure hydrocephalus in the spectrum of neurological complications of systemic lupus erythematosus. Neurol Sci. 2013;34:1009\u201313.","journal-title":"Neurol Sci"},{"key":"3432_CR50","first-page":"1119","volume":"77","author":"BT Klassen","year":"2011","unstructured":"Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold. water? Neurol. 2011;77:1119\u201325.","journal-title":"water? Neurol"},{"key":"3432_CR51","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12883-023-03496-w","volume":"23","author":"C Acarsoy","year":"2023","unstructured":"Acarsoy C, Ruiter R, Bos D, Ikram MK. No association between blood-based markers of immune system and migraine status: a population-based cohort study. BMC Neurol. 2023;23:445.","journal-title":"BMC Neurol"},{"key":"3432_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12864-018-4450-2","volume":"19","author":"ZF Gerring","year":"2018","unstructured":"Gerring ZF, McRae AF, Montgomery GW, Nyholt DR. Genome-wide DNA methylation profiling in whole blood reveals epigenetic signatures associated with migraine. BMC Genomics. 2018;19:69.","journal-title":"BMC Genomics"},{"key":"3432_CR53","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.arr.2021.101335","volume":"68","author":"BR Price","year":"2021","unstructured":"Price BR, Johnson LA, Norris CM. Reactive astrocytes: the nexus of pathological and clinical hallmarks of Alzheimer\u2019s disease. Ageing Res Rev. 2021;68:101335.","journal-title":"Ageing Res Rev"},{"key":"3432_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"3432_CR55","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, et al. Microglia use TAM receptors to detect and engulf amyloid beta plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"3432_CR56","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGFbeta-mediated checkpoints. Nat Immunol. 2023;24:1839\u201353.","journal-title":"Nat Immunol"},{"key":"3432_CR57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s43587-024-00583-6","volume":"4","author":"L Adams","year":"2024","unstructured":"Adams L, Song MK, Yuen S, Tanaka Y, Kim YS. A single-nuclei paired multiomic analysis of the human midbrain reveals age- and Parkinson\u2019s disease-associated glial changes. Nat Aging. 2024;4:364\u201378.","journal-title":"Nat Aging"},{"key":"3432_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan A, Ansari R, Pestana F, et al. Unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution. Mol Neurodegener. 2024;19:7.","journal-title":"Mol Neurodegener"},{"key":"3432_CR59","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20141732","volume":"212","author":"K Wu","year":"2015","unstructured":"Wu K, Byers DE, Jin X, et al. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. J Exp Med. 2015;212:681\u201397.","journal-title":"J Exp Med"},{"key":"3432_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Suarez-Calvet","year":"2019","unstructured":"Suarez-Calvet M, Morenas-Rodriguez E, Kleinberger G, et al. Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with Tau related-neurodegeneration but not with amyloid-beta pathology. Mol Neurodegener. 2019;14:1.","journal-title":"Mol Neurodegener"},{"key":"3432_CR61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ana.26891","volume":"95","author":"Y Li","year":"2024","unstructured":"Li Y, Yen D, Hendrix RD, et al. Timing of biomarker changes in sporadic Alzheimer\u2019s disease in estimated years from symptom onset. Ann Neurol. 2024;95:951\u201365.","journal-title":"Ann Neurol"},{"key":"3432_CR62","doi-asserted-by":"publisher","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","volume":"8","author":"M Suarez-Calvet","year":"2016","unstructured":"Suarez-Calvet M, Araque Caballero MA, Kleinberger G, et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury. Sci Transl Med. 2016;8:369ra178.","journal-title":"Sci Transl Med"},{"key":"3432_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","volume":"28","author":"C Franceschi","year":"2017","unstructured":"Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and \u2018Garb-aging\u2019. Trends Endocrinol Metab. 2017;28:199\u2013212.","journal-title":"Trends Endocrinol Metab"},{"key":"3432_CR64","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00011-008-7243-2","volume":"57","author":"S Giunta","year":"2008","unstructured":"Giunta S. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm- aging, from robustness to frailty. Inflamm Res. 2008;57:558\u201363.","journal-title":"Inflamm Res"},{"key":"3432_CR65","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/db12-1115","volume":"62","author":"VD Dixit","year":"2013","unstructured":"Dixit VD. Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant? Diabetes. 2013;62:22\u20134.","journal-title":"Diabetes"},{"key":"3432_CR66","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, et al. NLRP3 inflammasome activation drives Tau pathology. Nature. 2019;575:669\u201373.","journal-title":"Nature"},{"key":"3432_CR67","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","volume":"18","author":"YH Youm","year":"2013","unstructured":"Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18:519\u201332.","journal-title":"Cell Metab"},{"key":"3432_CR68","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/glia.20468","volume":"55","author":"A Sierra","year":"2007","unstructured":"Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia. 2007;55:412\u201324.","journal-title":"Glia"},{"key":"3432_CR69","doi-asserted-by":"crossref","unstructured":"Schafer MJ, Zhang X, Kumar A et al. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight. 2020;5.","DOI":"10.1172\/jci.insight.133668"},{"key":"3432_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12979-020-00196-8","volume":"17","author":"A Bektas","year":"2020","unstructured":"Bektas A, Schurman SH, Franceschi C, Ferrucci L. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17:23.","journal-title":"Immun Ageing"},{"key":"3432_CR71","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1093\/brain\/awad059","volume":"146","author":"JL Robinson","year":"2023","unstructured":"Robinson JL, Xie SX, Baer DR, et al. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated. Brain. 2023;146:2557\u201369.","journal-title":"Brain"},{"key":"3432_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2019.01.008","volume":"77","author":"AM Wennberg","year":"2019","unstructured":"Wennberg AM, Whitwell JL, Tosakulwong N, et al. The influence of Tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals. Neurobiol Aging. 2019;77:26\u201336.","journal-title":"Neurobiol Aging"},{"key":"3432_CR73","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","volume":"16","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr., Wiste HJ, Weigand SD, et al. Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study. Lancet Neurol. 2017;16:435\u201344.","journal-title":"Lancet Neurol"},{"key":"3432_CR74","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3233\/JAD-201565","volume":"81","author":"G Bostrom","year":"2021","unstructured":"Bostrom G, Freyhult E, Virhammar J, et al. Different inflammatory signatures in Alzheimer\u2019s disease and frontotemporal dementia cerebrospinal fluid. J Alzheimers Dis. 2021;81:629\u201340.","journal-title":"J Alzheimers Dis"},{"key":"3432_CR75","doi-asserted-by":"crossref","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci 2019;20.","DOI":"10.3390\/ijms20236008"},{"key":"3432_CR76","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","volume":"28","author":"FAJ Gigase","year":"2023","unstructured":"Gigase FAJ, Smith E, Collins B, et al. The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis. Mol Psychiatry. 2023;28:1502\u201315.","journal-title":"Mol Psychiatry"},{"key":"3432_CR77","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, Mila-Aloma M, Vrillon A, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum. JAMA Neurol. 2021;78:1471\u201383.","journal-title":"JAMA Neurol"},{"key":"3432_CR78","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, et al. The Alzheimer\u2019s association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 2022;18:2669\u201386.","journal-title":"Alzheimers Dement"},{"key":"3432_CR79","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/alz.12806","volume":"18","author":"J Simren","year":"2022","unstructured":"Simren J, Weninger H, Brum WS, et al. Differences between blood and cerebrospinal fluid glial fibrillary acidic protein levels: the effect of sample stability. Alzheimers Dement. 2022;18:1988\u201392.","journal-title":"Alzheimers Dement"},{"key":"3432_CR80","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","volume":"147","author":"P Sanchez-Juan","year":"2024","unstructured":"Sanchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonzalez A, et al. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain. 2024;147:1667\u201379.","journal-title":"Brain"},{"key":"3432_CR81","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1093\/cercor\/bhu157","volume":"25","author":"S Griemsmann","year":"2015","unstructured":"Griemsmann S, Hoft SP, Bedner P, et al. Characterization of Panglial gap junction networks in the thalamus, neocortex, and hippocampus reveals a unique population of glial cells. Cereb Cortex. 2015;25:3420\u201333.","journal-title":"Cereb Cortex"},{"key":"3432_CR82","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1471-4159.1991.tb08230.x","volume":"57","author":"JP O\u2019Callaghan","year":"1991","unstructured":"O\u2019Callaghan JP, Brinton RE, McEwen BS. Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J Neurochem. 1991;57:860\u20139.","journal-title":"J Neurochem"},{"key":"3432_CR83","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1038\/cddis.2013.194","volume":"4","author":"JJ Rodriguez","year":"2013","unstructured":"Rodriguez JJ, Terzieva S, Olabarria M, Lanza RG, Verkhratsky A. Enriched environment and physical activity reverse astrogliodegeneration in the hippocampus of AD Transgenic mice. Cell Death Dis. 2013;4:e678.","journal-title":"Cell Death Dis"},{"key":"3432_CR84","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Dorothee G, Heneka MT. Peripheral and central immune system crosstalk in alzheimer disease - a research prospectus. Nat Rev Neurol. 2021;17:689\u2013701.","journal-title":"Nat Rev Neurol"},{"key":"3432_CR85","doi-asserted-by":"publisher","first-page":"13050","DOI":"10.1038\/s41598-021-92101-6","volume":"11","author":"SH Park","year":"2021","unstructured":"Park SH, Lee EH, Kim HJ, et al. The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer\u2019s disease. Sci Rep. 2021;11:13050.","journal-title":"Sci Rep"},{"key":"3432_CR86","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1093\/brain\/awab399","volume":"144","author":"E Rodriguez-Vieitez","year":"2021","unstructured":"Rodriguez-Vieitez E, Ashton NJ. Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders. Brain. 2021;144:3283\u20135.","journal-title":"Brain"},{"key":"3432_CR87","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, et al. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26:416\u201329.","journal-title":"Nat Neurosci"},{"key":"3432_CR88","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","volume":"173","author":"MC Janelsins","year":"2008","unstructured":"Janelsins MC, Mastrangelo MA, Park KM, et al. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am J Pathol. 2008;173:1768\u201382.","journal-title":"Am J Pathol"},{"key":"3432_CR89","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12974-021-02200-4","volume":"18","author":"I Papazian","year":"2021","unstructured":"Papazian I, Tsoukala E, Boutou A, et al. Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKbeta promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice. J Neuroinflammation. 2021;18:222.","journal-title":"J Neuroinflammation"},{"key":"3432_CR90","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1523\/JNEUROSCI.0211-16.2016","volume":"36","author":"PM Madsen","year":"2016","unstructured":"Madsen PM, Motti D, Karmally S, et al. Oligodendroglial TNFR2 mediates membrane TNF-Dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination. J Neurosci. 2016;36:5128\u201343.","journal-title":"J Neurosci"},{"key":"3432_CR91","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano AJ, Xu Y, Tustison NJ, et al. Unexpected role of interferon-gamma in regulating neuronal connectivity and social behaviour. Nature. 2016;535:425\u20139.","journal-title":"Nature"},{"key":"3432_CR92","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pneurobio.2017.05.003","volume":"156","author":"S Monteiro","year":"2017","unstructured":"Monteiro S, Roque S, Marques F, Correia-Neves M, Cerqueira JJ. Brain interference: revisiting the role of IFNgamma in the central nervous system. Prog Neurobiol. 2017;156:149\u201363.","journal-title":"Prog Neurobiol"},{"key":"3432_CR93","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1096\/fj.07-099499","volume":"22","author":"T Mizuno","year":"2008","unstructured":"Mizuno T, Zhang G, Takeuchi H, et al. Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J. 2008;22:1797\u2013806.","journal-title":"FASEB J"},{"key":"3432_CR94","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00401-016-1541-5","volume":"131","author":"BH Clausen","year":"2016","unstructured":"Clausen BH, Lambertsen KL, Dagnaes-Hansen F, et al. Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke. Acta Neuropathol. 2016;131:775\u201391.","journal-title":"Acta Neuropathol"},{"key":"3432_CR95","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.immuni.2019.02.012","volume":"50","author":"X Liu","year":"2019","unstructured":"Liu X, Nemeth DP, McKim DB, et al. Cell-Type-Specific Interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities. Immunity. 2019;50:764\u20136.","journal-title":"Immunity"},{"key":"3432_CR96","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1084\/jem.164.2.594","volume":"164","author":"D Giulian","year":"1986","unstructured":"Giulian D, Baker TJ, Shih LC, Lachman LB. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med. 1986;164:594\u2013604.","journal-title":"J Exp Med"},{"key":"3432_CR97","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0006-8993(90)90445-H","volume":"514","author":"RM Lechan","year":"1990","unstructured":"Lechan RM, Toni R, Clark BD, et al. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 1990;514:135\u201340.","journal-title":"Brain Res"},{"key":"3432_CR98","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/00004647-199911000-00010","volume":"19","author":"S Suzuki","year":"1999","unstructured":"Suzuki S, Tanaka K, Nogawa S, et al. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1999;19:1256\u201362.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3432_CR99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(03)00136-8","volume":"341","author":"F Vollenweider","year":"2003","unstructured":"Vollenweider F, Herrmann M, Otten U, Nitsch C. Interleukin-6 receptor expression and localization after transient global ischemia in gerbil hippocampus. Neurosci Lett. 2003;341:49\u201352.","journal-title":"Neurosci Lett"},{"key":"3432_CR100","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbrc.2011.07.127","volume":"412","author":"W Ashutosh, Kou","year":"2011","unstructured":"Ashutosh, Kou W, Cotter R, et al. CXCL8 protects human neurons from amyloid-beta-induced neurotoxicity: relevance to Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2011;412:565\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"3432_CR101","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jnr.10744","volume":"74","author":"M Danik","year":"2003","unstructured":"Danik M, Puma C, Quirion R, Williams S. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. J Neurosci Res. 2003;74:286\u201395.","journal-title":"J Neurosci Res"},{"key":"3432_CR102","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/cdd.2008.79","volume":"15","author":"RH Fontaine","year":"2008","unstructured":"Fontaine RH, Cases O, Lelievre V, et al. IL-9\/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ. 2008;15:1542\u201352.","journal-title":"Cell Death Differ"},{"key":"3432_CR103","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41593-023-01435-z","volume":"26","author":"M Andreadou","year":"2023","unstructured":"Andreadou M, Ingelfinger F, De Feo D, et al. IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nat Neurosci. 2023;26:1701\u201312.","journal-title":"Nat Neurosci"},{"key":"3432_CR104","doi-asserted-by":"publisher","first-page":"11281","DOI":"10.1523\/JNEUROSCI.1685-15.2015","volume":"35","author":"X Zhao","year":"2015","unstructured":"Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J. Neuronal Interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci. 2015;35:11281\u201391.","journal-title":"J Neurosci"},{"key":"3432_CR105","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20091419","volume":"207","author":"NC Derecki","year":"2010","unstructured":"Derecki NC, Cardani AN, Yang CH, et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207:1067\u201380.","journal-title":"J Exp Med"},{"key":"3432_CR106","doi-asserted-by":"crossref","unstructured":"Hanuscheck N, Thalman C, Domingues M et al. Interleukin-4 receptor signaling modulates neuronal network activity. J Exp Med 2022;219.","DOI":"10.1084\/jem.20211887"},{"key":"3432_CR107","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41467-023-35806-8","volume":"14","author":"S Li","year":"2023","unstructured":"Li S, Olde Heuvel F, Rehman R, et al. Interleukin-13 and its receptor are synaptic proteins involved in plasticity and neuroprotection. Nat Commun. 2023;14:200.","journal-title":"Nat Commun"},{"key":"3432_CR108","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0301-0082(97)00066-X","volume":"54","author":"KC Flanders","year":"1998","unstructured":"Flanders KC, Ren RF, Lippa CF. Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol. 1998;54:71\u201385.","journal-title":"Prog Neurobiol"},{"key":"3432_CR109","doi-asserted-by":"publisher","first-page":"e59250","DOI":"10.1371\/journal.pone.0059250","volume":"8","author":"TT Logan","year":"2013","unstructured":"Logan TT, Villapol S, Symes AJ. TGF-beta superfamily gene expression and induction of the Runx1 transcription factor in adult neurogenic regions after brain injury. PLoS ONE. 2013;8:e59250.","journal-title":"PLoS ONE"},{"key":"3432_CR110","doi-asserted-by":"publisher","first-page":"110094","DOI":"10.1016\/j.celrep.2021.110094","volume":"37","author":"M Di Filippo","year":"2021","unstructured":"Di Filippo M, Mancini A, Bellingacci L, et al. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis. Cell Rep. 2021;37:110094.","journal-title":"Cell Rep"},{"key":"3432_CR111","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-7-9","volume":"7","author":"S Alboni","year":"2010","unstructured":"Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9.","journal-title":"J Neuroinflammation"},{"key":"3432_CR112","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","volume":"108","author":"MQ Xia","year":"2000","unstructured":"Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer\u2019s disease. J Neuroimmunol. 2000;108:227\u201335.","journal-title":"J Neuroimmunol"},{"key":"3432_CR113","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1471-4159.2002.00809.x","volume":"81","author":"G Banisadr","year":"2002","unstructured":"Banisadr G, Queraud-Lesaux F, Boutterin MC, et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem. 2002;81:257\u201369.","journal-title":"J Neurochem"},{"key":"3432_CR114","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pneurobio.2010.12.003","volume":"93","author":"S Sorce","year":"2011","unstructured":"Sorce S, Myburgh R, Krause KH. The chemokine receptor CCR5 in the central nervous system. Prog Neurobiol. 2011;93:297\u2013311.","journal-title":"Prog Neurobiol"},{"key":"3432_CR115","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0006-8993(88)91369-8","volume":"438","author":"F Gomez-Pinilla","year":"1988","unstructured":"Gomez-Pinilla F, Knauer DJ, Nieto-Sampedro M. Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization. Brain Res. 1988;438:385\u201390.","journal-title":"Brain Res"},{"key":"3432_CR116","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0301-0082(96)00046-9","volume":"51","author":"M Yamada","year":"1997","unstructured":"Yamada M, Ikeuchi T, Hatanaka H. The neurotrophic action and signalling of epidermal growth factor. Prog Neurobiol. 1997;51:19\u201337.","journal-title":"Prog Neurobiol"},{"key":"3432_CR117","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164\u201378.","journal-title":"Cell"},{"key":"3432_CR118","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M","volume":"26","author":"N Davoust","year":"1999","unstructured":"Davoust N, Jones J, Stahel PF, Ames RS, Barnum SR. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia. 1999;26:201\u201311.","journal-title":"Glia"},{"key":"3432_CR119","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.4049\/jimmunol.166.6.4154","volume":"166","author":"SA O\u2019Barr","year":"2001","unstructured":"O\u2019Barr SA, Caguioa J, Gruol D, et al. Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol. 2001;166:4154\u201362.","journal-title":"J Immunol"},{"key":"3432_CR120","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/glia.24355","volume":"71","author":"N Daskoulidou","year":"2023","unstructured":"Daskoulidou N, Shaw B, Torvell M, et al. Complement receptor 1 is expressed on brain cells and in the human brain. Glia. 2023;71:1522\u201335.","journal-title":"Glia"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:02:50Z","timestamp":1744729370000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03432-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MGT is co-inventor of Xencor\u2019s XPro1595, a soluble TNF-specific biologic under clinical development by INmune Bio for neurological indications. MGT is a consultant\/advisor INmune Bio, Merck, Cellestial Therapeutics, Forward Therapeutics, Jaya, NysnoBio Longevity Biotech, Longeveron, iMetabolic Pharm, NovoNordisk, IMMvention, Ventus. MGT has served as an advisor\/member on the Medical and Scientific Advisory Group of the Alzheimer\u2019s Association, Weston Family Foundation of Canada, Parkinson\u2019s Foundation, Parkinson\u2019s UK, World Parkinson Coalition, MJ Fox Foundation for Parkinson\u2019s Research, and the Alzheimer\u2019s Disease Cooperative Study Intervention Selection Committee (ADCS-ISC), and the International Linked Clinical Trials (iLCT) of the Cure Parkinson\u2019s Trust. MGT has served on grant review panels for NIH, MF Fox Foundation, Weston Family Foundation, Alzheimer\u2019s Association, Bright Focus Foundation, Alzheimer\u2019s Drug Discovery Foundation (ADDF), Parkinson\u2019s UK. MGT has served as Editor-in-Chief for Nature Partner Journal Parkinson\u2019s Disease, Associate Editor for Science Advances, Alzheimer\u2019s & Dementia: Translational Research and Clinical Interventions (AE), and Journal of Neuroinflammation. WTH has received research support from NIH, Robert Wood Johnson Foundation, Fujirebio Diagnostics Inc, Atlanta Family Foundation, and TMCity Foundation; has consulted for Apellis Pharmaceuticals, Beckman Coulter Diagnostics, Biogen, Fujirebio Diagnostics Inc; has patents on CSF-based diagnosis of FTLD-TDP, prognosis of MCI due to AD, and prognosis of spinal muscular atrophy on gene therapy; and has copyright on Mandarin-based cognitive assessments (licensed to Linus Health).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}